Value Attribution in the Decision to Use of Whole Body MRI for Early Cancer Diagnosis.

cancer screening decision aids diffusion whole body magnetic resonance preferences

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
28 May 2021
Historique:
received: 15 03 2021
revised: 18 05 2021
accepted: 26 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

This study aimed to identify the main factors that asymptomatic individuals considered when deciding to undergo self-referred Whole-body MRI (WB-MRI) for early cancer diagnosis and the subjective values attributed to each mentioned factor in a Decision tree analysis. Personal characteristics such as risk perception and personality were investigated as possible factors affecting value attribution. Seventy-four volunteers (mean age 56.4; male = 47) filled a simplified decision tree by expressing the expected factors and related subjective values associated with two screening options for early cancer diagnosis (standard procedures vs. WB-MRI+standard procedures) while waiting for a WB-MRI examination. Questionnaires on risk perception and personality traits were also administered. Expected factors were summarized in 5 clusters: diagnostic certainty, psychological well-being, safety, test validity and time/cost. Test validity and time/cost were evaluated as potential losses in both procedures. Diagnostic Certainty and safety were evaluated as losses in standard screening, and as an advantage when considering WB-MRI+standard screening. Forty-five percent of participants considered WB-MRI+standard screening as beneficial for their psychological well-being. Finally, personal absolute and comparative risk to get cancer was associated with a positive value attribution to WB-MRI (

Identifiants

pubmed: 34071199
pii: diagnostics11060972
doi: 10.3390/diagnostics11060972
pmc: PMC8227751
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Eur Urol. 2017 Jan;71(1):81-92
pubmed: 27317091
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2167-73
pubmed: 17119042
Cancer Imaging. 2020 May 11;20(1):34
pubmed: 32393345
Risk Anal. 2007 Feb;27(1):171-85
pubmed: 17362408
J Behav Med. 2006 Feb;29(1):37-49
pubmed: 16470344
Med Sci Sports Exerc. 2003 Nov;35(11):1823-7
pubmed: 14600545
CA Cancer J Clin. 2007 May-Jun;57(3):147-67
pubmed: 17507441
Risk Anal. 2004 Oct;24(5):1349-67
pubmed: 15563300
Acta Psychol (Amst). 2003 May;113(1):67-81
pubmed: 12679044
Magn Reson Imaging Clin N Am. 2018 Nov;26(4):495-507
pubmed: 30316463
Eur Radiol. 2019 Jul;29(7):3889-3900
pubmed: 30937589
Addict Behav. 2020 Apr;103:106222
pubmed: 31838445
Cognition. 1993 Oct-Nov;49(1-2):37-66
pubmed: 8287674
Ecancermedicalscience. 2019 Mar 28;13:914
pubmed: 31123497
J Med Genet. 2020 Apr;57(4):226-236
pubmed: 31719169
Radiol Med. 2019 Mar;124(3):218-233
pubmed: 30430385
Prev Med. 2000 Dec;31(6):714-21
pubmed: 11133339
Crit Rev Oncol Hematol. 2016 Apr;100:69-73
pubmed: 26852078
Radiology. 2019 Apr;291(1):5-13
pubmed: 30806604
Br J Radiol. 2021 Feb 1;94(1118):20191031
pubmed: 33237810
BMC Public Health. 2012 Jan 25;12:80
pubmed: 22276600
Patient Prefer Adherence. 2015 Nov 23;9:1677-86
pubmed: 26648700
J Environ Public Health. 2009;2009:891754
pubmed: 20041018
Clin Imaging. 2018 Nov - Dec;52:246-251
pubmed: 30170274
Science. 1981 Jan 30;211(4481):453-8
pubmed: 7455683

Auteurs

Derna Busacchio (D)

Applied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
Division of Radiology, IEO European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Ketti Mazzocco (K)

Applied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.

Davide Radice (D)

Division of Epidemiology and Biostatistics, IEO European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Paul E Summers (PE)

Division of Radiology, IEO European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Paola Pricolo (P)

Division of Radiology, IEO European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Gabriella Pravettoni (G)

Applied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.

Giuseppe Petralia (G)

Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Precision Imaging and Research Unit, Department of Medical Imaging and Radiation Sciences, IEO European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Classifications MeSH